OVEREXPRESSION OF P53 PROTEIN IN BARRETTS SYNDROME WITH MALIGNANT TRANSFORMATION

被引:72
作者
FLEJOU, JF
POTET, F
MUZEAU, F
LEPELLETIER, F
FEKETE, F
HENIN, D
机构
[1] HOP BEAUJON, DEPT PATHOL, F-92118 CLICHY, FRANCE
[2] HOP BEAUJON, DEPT DIGEST SURG, F-92118 CLICHY, FRANCE
[3] UNIV PARIS 07, INSERM, U239, PARIS, FRANCE
关键词
D O I
10.1136/jcp.46.4.330
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To study the overexpression of p53 protein in Barrett's oesophagus with adenocarcinoma, and to correlate this expression with the pathological features of Barrett's syndrome. Methods-Immunohistochemical staining was performed on frozen sections with a monoclonal antibody directed against wild type and mutated p53 protein (Pab 1801). Eleven cases of Barrett's adenocarcinoma were studied, seven of which had extensive sampling of benign Barrett's mucosa. Results-Eight of 11 adenocarcinomas overexpressed the p53 protein. Both early and advanced tumours were positive. In Barrett's mucosa around the p53 positive tumours, high grade dysplasia was positive; low grade dysplasia and non-dysplastic mucosa were negative. Conclusions-P53 gene mutation with ensuing p53 protein overexpression is a common feature of Barrett's adenocarcinoma, both at early and advanced stages. This mutation appears as a relatively late event during the neoplastic transformation of Barrett's oesophagus.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 30 条
[1]   HIGH-GRADE DYSPLASIA IN THE COLUMNAR-LINED ESOPHAGUS [J].
ALTORKI, NK ;
SUNAGAWA, M ;
LITTLE, AG ;
SKINNER, DB .
AMERICAN JOURNAL OF SURGERY, 1991, 161 (01) :97-100
[2]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[3]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[4]  
BARTEK J, 1991, ONCOGENE, V6, P1699
[5]   PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO [J].
BARTEK, J ;
BARTKOVA, J ;
VOJTESEK, B ;
STASKOVA, Z ;
REJTHAR, A ;
KOVARIK, J ;
LANE, DP .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) :839-844
[6]  
CAMPO E, 1991, CANCER RES, V51, P4436
[7]  
CASSON AG, 1991, CANCER RES, V51, P4495
[8]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[9]   BARRETTS ESOPHAGUS - DEVELOPMENT OF DYSPLASIA AND ADENOCARCINOMA [J].
HAMEETEMAN, W ;
TYTGAT, GNJ ;
HOUTHOFF, HJ ;
VANDENTWEEL, JG .
GASTROENTEROLOGY, 1989, 96 (05) :1249-1256
[10]   THE RELATIONSHIP BETWEEN COLUMNAR EPITHELIAL DYSPLASIA AND INVASIVE ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS [J].
HAMILTON, SR ;
SMITH, RRL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (03) :301-312